245 related articles for article (PubMed ID: 21645211)
1. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
[TBL] [Abstract][Full Text] [Related]
2. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.
Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Kaiser GM; Schmid KW; Baba HA
J Clin Pathol; 2009 Aug; 62(8):690-3. PubMed ID: 19638539
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
[TBL] [Abstract][Full Text] [Related]
4. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
[TBL] [Abstract][Full Text] [Related]
5. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
6. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
7. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A
J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
[TBL] [Abstract][Full Text] [Related]
9. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Malago M; Steveling K; Reis H; Cicinnati VR; Schmid KW; Baba HA
J Hepatol; 2008 Jan; 48(1):83-90. PubMed ID: 17998146
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
[TBL] [Abstract][Full Text] [Related]
12. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
14. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T
J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
[TBL] [Abstract][Full Text] [Related]
17. Morphologic classification of microvessels in hepatocellular carcinoma is associated with the prognosis after resection.
Chen ZY; Wei W; Guo ZX; Lin JR; Shi M; Guo RP
J Gastroenterol Hepatol; 2011 May; 26(5):866-74. PubMed ID: 21488945
[TBL] [Abstract][Full Text] [Related]
18. Recent advances of radiofrequency ablation for early hepatocellular carcinoma.
Izumi N
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():115-22. PubMed ID: 21199522
[TBL] [Abstract][Full Text] [Related]
19. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
[TBL] [Abstract][Full Text] [Related]
20. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]